c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naive prostate cancer that retains RB expression Meeting Abstract


Authors: Kelly, W. K.; Godwin, J. L.; Hoffman-Censits, J. H.; Knudsen, K. E.; De Leeuw, R.; Leiby, B. E.; Southwell, T.; Hubert, C.; Smith, D. C.; Chatta, G. S.; Aghalar, J.; Scher, H. I.; Bose, R.; Autio, K. A.; Abida, W.; Slovin, S. F.
Abstract Title: c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naive prostate cancer that retains RB expression
Meeting Title: 2018 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 6 Suppl.
Meeting Dates: 2018 Feb 8-10
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-20
Language: English
ACCESSION: WOS:000436179500378
DOI: 10.1200/JCO.2018.36.6_suppl.TPS384
PROVIDER: wos
Notes: Meeting Abstract: TPS384 -- Source: Wos
Altmetric Score
MSK Authors
  1. Susan Slovin
    178 Slovin
  2. Karen Anne Autio
    39 Autio
  3. Howard Scher
    756 Scher
  4. Wassim Abida
    36 Abida
  5. Rohit   Bose
    3 Bose